Positive results in study of VaxGen's smallpox vaccine
6th Sep 2005, 01:02 GMT
A study has shown that a single dose of VaxGen's smallpox vaccine candidate LC16m8 provides mice with 100% protection from vaccinia, a relative of the smallpox virus.
Latest news from Pharmaceutical Business Review Online:
- Celesio revenues, profits up
- Amgen arthritis drug shows sustained safety and efficacy
- Study supports cardiovascular safety of naproxen
- Cangene chickenpox drug granted orphan status
- Reata brain cancer therapy shows strong activity
- Novartis diabetes drug faces three month delay
- Favrille drug fails secondary goal
- Neurogen commences human testing of obesity drug
- Aeterna prostate cancer drug shows promise
- Isis says new drug effective against cholesterol